Cargando…
Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection
SIMPLE SUMMARY: Gastric cancer (GC) is the fifth most common cancer worldwide and the fourth most common cause of cancer-related deaths, with a high frequency of recurrence and metastasis, and a poor prognosis. This study presents a novel combination of four proteins (PDGFRB, INHBA, MMP11, and galec...
Autores principales: | Hashimoto, Itaru, Kimura, Yayoi, Oue, Naohide, Hiroshima, Yukihiko, Aoyama, Toru, Rino, Yasushi, Yokose, Tomoyuki, Yasui, Wataru, Miyagi, Yohei, Oshima, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497152/ https://www.ncbi.nlm.nih.gov/pubmed/36139587 http://dx.doi.org/10.3390/cancers14184427 |
Ejemplares similares
-
High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1
por: Maezawa, Yukio, et al.
Publicado: (2019) -
Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial
por: Oshima, Takashi, et al.
Publicado: (2020) -
Clinical Significance of the Prealbumin Level in Gastric Cancer Patients Who Receive Curative Treatment
por: Aoyama, Toru, et al.
Publicado: (2021) -
Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
por: Aoyama, Toru, et al.
Publicado: (2017) -
Clinicopathologic and molecular characteristics of gastric cancer showing gastric and intestinal mucin phenotype
por: Oue, Naohide, et al.
Publicado: (2015)